Strides to acquire 18 abbreviated new drug applications from Pharmaceutics International, Inc

Strides to acquire 18 abbreviated new drug applications from Pharmaceutics International, Inc "Strides...announced that its step-down wholly-owned subsidiary, Strides Pharma Global Pte Ltd, Singapore, has entered into a definitive asset transfer and licensing agreement with Pharmaceutics International, Inc (Pii) to acquire 18 ANDAs for the US market," the company said in a filing to BSE.

No comments:

Post a Comment